Clinical trials
Phase 4 trials in Nepal
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2011 | 5 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2017 | 3 |
| 2018 | 10 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 4 |
| 2023 | 4 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Unknown status | 12 |
| Not yet recruiting | 4 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| B.P. Koirala Institute of Health Sciences | 17 |
| Gynuity Health Projects | 3 |
| Oxford University Clinical Research Unit, Vietnam | 3 |
| Tribhuvan University Teaching Hospital, Institute Of Medicine. | 3 |
| Lumbini Medical College | 2 |
| Population Health Research Institute | 2 |
| Dr. Aayush Khanal, MD | 1 |
| International Union Against Tuberculosis and Lung Diseases | 1 |
| Johns Hopkins University | 1 |
| Kathmandu University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Postoperative Pain | 6 |
| Typhoid Fever | 3 |
| Altitude Sickness | 2 |
| Atrial Fibrillation | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Anxiety Disorders | 1 |
| Asthma | 1 |
| Bronchiolitis | 1 |
| COVID-19 | 1 |
| Cough | 1 |
Trials
Showing 51 to 46 of 46. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.